In addition, stable over-expression or knockdown of ITLN1 resulted in increased and decreased NDRG2 promoter activity in NB cells, respectively, especially at −395/+192 bp region relative to the transcription start site (TSS) (Figure 1 F). The gene discussed is NDRG2; the disease is neuroblastoma.